Dompé and Axxam Announce Drug Discovery and Development Collaboration

Dompé s.p.a. and Axxam SpA announced a research collaboration for the discovery and development of novel drugs based on GPCR targets. Scientists from both companies will contribute to the drug discovery and development process for relevant disease targets. Steps in the process include target identification,assay development, library assembly, screening, medicinal chemistry, hit to lead optimization, pharmacology, and preclinical and clinical development. Dompé will bring expertise in the field of medicinal chemistry, oriented to the rational drug design of small molecular weight GPCRs modulators and in the pre-clinical and clinical development of innovative drugs. Axxam will contribute its own experience and know-how in target biology, assay development and high-throughput screening.